These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH. Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794 [Abstract] [Full Text] [Related]
12. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Anand P, Singh B, Singh N. Bioorg Med Chem; 2012 Feb 01; 20(3):1175-80. PubMed ID: 22257528 [Abstract] [Full Text] [Related]
15. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. Tong W, Collantes ER, Chen Y, Welsh WJ. J Med Chem; 1996 Jan 19; 39(2):380-7. PubMed ID: 8558505 [Abstract] [Full Text] [Related]
16. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents. Anand P, Singh B. Bioorg Med Chem; 2012 Jan 01; 20(1):521-30. PubMed ID: 22172310 [Abstract] [Full Text] [Related]
18. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Huang L, Shi A, He F, Li X. Bioorg Med Chem; 2010 Feb 01; 18(3):1244-51. PubMed ID: 20056426 [Abstract] [Full Text] [Related]